Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
INVO Bioscience (INVO)
NASDAQ:INVO
INVO Bioscience (INVO) Stock Price & Analysis
110 Followers
INVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.50 - $10.48
Previous Close$1.52
Volume5.05M
Average Volume (3M)3.82M
Market Cap
$4.17M
Enterprise Value$8.16M
Total Cash (Recent Filing)$112.48K
Total Debt (Recent Filing)$4.10M
Price to Earnings (P/E)-0.2
Beta1.15
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.66
Shares Outstanding2,743,031
10 Day Avg. Volume22,974,728
30 Day Avg. Volume3,822,337
Standard Deviation0.28
R-Squared0.07
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-0.20
Price to Sales (P/S)17.95
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.66
Enterprise Value/Gross Profit15.24
Enterprise Value/Ebitda-2.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
INVO Bioscience News
PremiumCompany Announcements
INVO Bioscience Navigates Lease Assignment and Nasdaq Woes
PremiumCompany Announcements
INVO Bioscience Seeks Funds After NAYA Misses Deadline
Ownership Overview
59.76%
Insiders
2.80% Mutual Funds
1.98% Other Institutional Investors
35.47% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INVO FAQ
What was INVO Bioscience’s price range in the past 12 months?
INVO Bioscience lowest stock price was $0.50 and its highest was $10.48 in the past 12 months.
What is INVO Bioscience’s market cap?
Currently, no data Available
When is INVO Bioscience’s upcoming earnings report date?
INVO Bioscience’s upcoming earnings report date is May 13, 2024 which is in 19 days.
How were INVO Bioscience’s earnings last quarter?
Currently, no data Available
Is INVO Bioscience overvalued?
According to Wall Street analysts INVO Bioscience’s price is currently Overvalued.
Does INVO Bioscience pay dividends?
INVO Bioscience does not currently pay dividends.
What is INVO Bioscience’s EPS estimate?
INVO Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INVO Bioscience have?
INVO Bioscience has 2,743,031 shares outstanding.
What happened to INVO Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of INVO Bioscience?
Currently, no hedge funds are holding shares in INVO
---
INVO Bioscience Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Positive
Last 7 Days ▲ 29.8%
Last 30 Days ▲ 26.2%
Last 30 Days ▲ 26.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.15%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
409.00%
Trailing 12-Months
Company Description
INVO Bioscience
INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.
---
INVO Earnings Call
Q2 2023
0:00 / 0:00
---
INVO Stock 12 Months Forecast
Average Price Target
―Technical Analysis
---